Staging, risk assessment and screening of breast cancer
Breast cancer is the most common female malignant disease in the western countries where a woman's lifetime risk of developing the disease is more than 10 %. Nulliparity or use of hormonal replacement therapy, strong family history, or a history of therapeutic thoracic radiation are considerabl...
Gespeichert in:
| Veröffentlicht in: | Experimental Oncology |
|---|---|
| Datum: | 2013 |
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | Englisch |
| Veröffentlicht: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2013
|
| Schlagworte: | |
| Online Zugang: | https://nasplib.isofts.kiev.ua/handle/123456789/145232 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Zitieren: | Staging, risk assessment and screening of breast cancer / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 238-245. — Бібліогр.: 85 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of Ukraine| _version_ | 1862738814695374848 |
|---|---|
| author | Yalcin, B. |
| author_facet | Yalcin, B. |
| citation_txt | Staging, risk assessment and screening of breast cancer / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 238-245. — Бібліогр.: 85 назв. — англ. |
| collection | DSpace DC |
| container_title | Experimental Oncology |
| description | Breast cancer is the most common female malignant disease in the western countries where a woman's lifetime risk of developing the disease is more than 10 %. Nulliparity or use of hormonal replacement therapy, strong family history, or a history of therapeutic thoracic radiation are considerable high risk factors for the development of breast cancer. Nowadays more new effective therapeutic agents have been developed for the intervention of the breast cancer, but prognosis is still remained poor in the metastatic disease. For the general population, screening mammography in women older than 40 - 45 years has been shown to be effective in identifying early-stage breast cancer and in decreasing the mortality rate. In randomized screening mammography trials for breast cancer, it has been established that screening mammograms reduced breast cancer mortality in women older than 50 years of age by 25 to 30%. This review article summarizes the risk factors for developing breast cancer, methods for risk assessment and the accepted screening guidelines.
|
| first_indexed | 2025-12-07T20:05:43Z |
| format | Article |
| fulltext | |
| id | nasplib_isofts_kiev_ua-123456789-145232 |
| institution | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| issn | 1812-9269 |
| language | English |
| last_indexed | 2025-12-07T20:05:43Z |
| publishDate | 2013 |
| publisher | Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| record_format | dspace |
| spelling | Yalcin, B. 2019-01-19T17:35:10Z 2019-01-19T17:35:10Z 2013 Staging, risk assessment and screening of breast cancer / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 238-245. — Бібліогр.: 85 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/145232 Breast cancer is the most common female malignant disease in the western countries where a woman's lifetime risk of developing the disease is more than 10 %. Nulliparity or use of hormonal replacement therapy, strong family history, or a history of therapeutic thoracic radiation are considerable high risk factors for the development of breast cancer. Nowadays more new effective therapeutic agents have been developed for the intervention of the breast cancer, but prognosis is still remained poor in the metastatic disease. For the general population, screening mammography in women older than 40 - 45 years has been shown to be effective in identifying early-stage breast cancer and in decreasing the mortality rate. In randomized screening mammography trials for breast cancer, it has been established that screening mammograms reduced breast cancer mortality in women older than 50 years of age by 25 to 30%. This review article summarizes the risk factors for developing breast cancer, methods for risk assessment and the accepted screening guidelines. en Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України Experimental Oncology Special issue on breast cancer Staging, risk assessment and screening of breast cancer Article published earlier |
| spellingShingle | Staging, risk assessment and screening of breast cancer Yalcin, B. Special issue on breast cancer |
| title | Staging, risk assessment and screening of breast cancer |
| title_full | Staging, risk assessment and screening of breast cancer |
| title_fullStr | Staging, risk assessment and screening of breast cancer |
| title_full_unstemmed | Staging, risk assessment and screening of breast cancer |
| title_short | Staging, risk assessment and screening of breast cancer |
| title_sort | staging, risk assessment and screening of breast cancer |
| topic | Special issue on breast cancer |
| topic_facet | Special issue on breast cancer |
| url | https://nasplib.isofts.kiev.ua/handle/123456789/145232 |
| work_keys_str_mv | AT yalcinb stagingriskassessmentandscreeningofbreastcancer |